MedPath

Evaluation of Therapeutic Effect of 0.5 mg Colchicine and 5 mg Prednisolone on Oral Aphthae

Phase 2
Conditions
Oral Aphthae
Interventions
Registration Number
NCT00723268
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

The purpose of this study is to determine whether low doses of prednisolone, or colchicine are effective in the treatment of oral aphthae.

Detailed Description

Treatment of recurrent aphthous stomatitis (RAS) remains, to date, empirical and non-specific. The main goals of therapy are to minimize pain and functional disabilities as well as decrease inflammatory reactions and frequency of recurrences.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Confirmation of clinical diagnosis of aphthae
  • Having the experience of oral aphthae at least once in a month
  • Two weeks wash out periods after the last treatment
Exclusion Criteria
  • History of any systemic disease
  • Using drugs which affect immune system
  • Pregnancy and breast feeding
  • Aphthous related syndromes

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ColchicineColchicine-
PrednisolonePrednisolone-
Primary Outcome Measures
NameTimeMethod
frequency of ulcers1 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mashhad Dental school

🇮🇷

Mashhad, Khorasan Razavi, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath